ZAMBON, ALBERTO
ZAMBON, ALBERTO
Dipartimento di Medicina - DIMED
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.
2011 Mikhailidis, Dp; Elisaf, M; Rizzo, M; Berneis, K; Griffin, B; Zambon, Alberto; Athyros, V; de Graaf, J; März, W; Parhofer, Kg; Rini, Gb; Spinas, Ga; Tomkin, Gh; Tselepis, Ad; Wierzbicki, As; Winkler, K; Florentin, M; Liberopoulos, E.
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary.
2011 Mikhailidis, Dp; Elisaf, M; Rizzo, M; Berneis, K; Griffin, B; Zambon, Alberto; Athyros, V; de Graaf, J; März, W; Parhofer, Kg; Rini, Gb; Spinas, Ga; Tomkin, Gh; Tselepis, Ad; Wierzbicki, As; Winkler, K; Florentin, M; Liberopoulos, E.
[Dyslipidemia in visceral obesity: pathophysiological mechanisms, clinical implications and therapy].
2008 Zambon, Alberto; Marchiori, M; Manzato, Enzo
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy]
2023 Arca, Marcello; Averna, Maurizio; Borghi, Claudio; Lettino, Maddalena; Perrone Filardi, Pasquale; Alberti, Antonia; Bilato, Claudio; Calabrò, Paolo; Carubbi, Francesca; Ciccone, Marco Matteo; Cipollone, Francesco; Citroni, Nadia; De Luca, Leonardo; Giaccari, Andrea; Iannuzzo, Gabriella; Maloberti, Alessandro; Marcucci, Rossella; Pignatelli Spinazzola, Pasquale; Pirro, Matteo; Pisciotta, Livia; Sarullo, Filippo; Sciacqua, Angela; Suppressa, Patrizia; Varbella, Ferdinando; Werba, José Pablo; Zambon, Alberto
A common hepatic lipase gene promoter variant determines clinical response to intensive lipid lowering treatment
2001 Zambon, Alberto; Deeb, S. S.; Hokanson, J. E.; Brown, B. G.; Brunzell, J. D.
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy
2015 Aguiar, Carlos; Alegria, Eduardo; Bonadonna, Riccardo C.; Catapano, Alberico L.; Cosentino, Francesco; Elisaf, Moses; Farnier, Michel; Ferrières, Jean; Filardi, Pasquale Perrone; Hancu, Nicolae; Kayikcioglu, Meral; Mello e. Silva, Alberto; Millan, Jesus; Reiner, Željko; Tokgozoglu, Lale; Valensi, Paul; Viigimaa, Margus; Vrablik, Michal; Zambon, Alberto; Zamorano, José Luis; Ferrari, Roberto
A subgroup analysis of the ODYSSEY APPRISE study: safety and efficacy of alirocumab in the Italian cohort
2022 Cefalù, Angelo B.; Garbelotto, Raffaella; Mombelli, Giuliana; Pirro, Matteo; Rubba, Paolo; Arca, Marcello; Borghi, Claudio; Bonomo, Katia; Gonnelli, Stefano; Massaroni, Katia; Tirone, Giampaolo; Averna, Maurizio; Angelico, Francesco; Cipollone, Francesco; Corghi, Enzo; Faggiano, Pompilio; Greco, Cesare; Guasti, Luigina; Lucchi, Tiziano; Sabba, Carlo; Sarzani, Riccardo; Terrosu, Pierfranco; Zambon, Alberto
Accuracy of diagnostic criteria for sporadic Creutzfeldt-Jakob disease among rapidly progressive dementia
2013 Tagliapietra, M; Zanusso, G; Fiorini, M; Bonetto, N; Zarantonello, G; Zambon, Alberto; Ermani, Mario; Monaco, S; Manara, R; Cagnin, Annachiara
ANALYSIS OF TECHNIQUES TO OBTAIN PLASMA FOR MEASUREMENTS OF LEVELS OF FREE FATTY ACIDS
1993 Zambon, Alberto; Hashimoto, S. I.; Brunzell, J. D.
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts
2020 Lettino, M.; Zambon, A.; Musumeci, G.; Arca, M.; Bilato, C.; Brunetti, N. D.; Calabro, P.; Casu, G.; Chiarella, F.; Faggiano, P.; Ferlini, M.; Guardigli, G.; Imbalzano, E.; Indolfi, C.; Marcucci, R.; Menozzi, A.; Mureddu, G. F.; Filardi, P. P.; Pirro, M.; Pisciotta, L.; Scherillo, M.; Suppressa, P.; Uguccioni, M.; Varbella, F.; Gentile, L.; Rapezzi, C.; Averna, M.
Association between the -514 C to T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis
2002 Faggin, Elisabetta; Zambon, Alberto; Puato, M; Deeb, S. S.; Bertocco, S; Sartore, Saverio; Crepaldi, Gaetano; Pessina, ACHILLE CESARE; Pauletto, Paolo
Atorvastatin Reduces Macrophage Accumulation in Atherosclerotic Plaques. A Comparison of a Nonstatin-Based Regimen in Patients Undergoing Carotid Endarterectomy.
2010 Puato, M; Faggin, Elisabetta; Rattazzi, Marcello; Zambon, Alberto; Cipollone, F; Grego, Franco; Ganassin, L; Plebani, Mario; Mezzetti, A; Pauletto, Paolo
Atorvastatin Reduces Macrophage Accumulation in the Atherosclerotic Plaque: A Comparison versus Non-statin Based Regimen in Patients Undergoing Carotid Endarterectomy
2009 Puato, M; Faggin, Elisabetta; Rattazzi, Marcello; Cipollone, F; Zambon, Alberto; Grego, Franco; Mezzetti, A; Pauletto, Paolo
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes
2018 D'Erasmo, Laura; Minicocci, Ilenia; Nicolucci, Antonio; Pintus, Paolo; Roeters Van Lennep, Janine E.; Masana, Luis; Mata, Pedro; Sánchez-Hernández, Rosa Maria; Prieto-Matos, Pablo; Real, Josè T.; Ascaso, Juan F.; Lafuente, Eduardo Esteve; Pocovi, Miguel; Fuentes, Francisco J.; Muntoni, Sandro; Bertolini, Stefano; Sirtori, Cesare; Calabresi, Laura; Pavanello, Chiara; Averna, Maurizio; Cefalu, Angelo Baldassare; Noto, Davide; Pacifico, Adolfo Arturo; Pes, Giovanni Mario; Harada-Shiba, Mariko; Manzato, Enzo; Zambon, Sabina; Zambon, Alberto; Vogt, Anja; Scardapane, Marco; Sjouke, Barbara; Fellin, Renato; Arca, Marcello
C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?
2003 Rattazzi, Marcello; Puato, M.; Faggin, E; Bertipaglia, B; Zambon, Alberto; Pauletto, Paolo
Changes in LDL density across the menopausal transition
2000 Kim, K. H.; Carr, C. C.; Zambon, Alberto; Mitchell, M. S.; Woods, N. F.; Casazza, C. P.; Hokanson, J. E.; Brunzell, J. D.; Schwartz, R. S.
Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: impact of plaque composition and lipoprotein phenotype.
2006 Zambon, Alberto; Puato, M; Faggin, Elisabetta; Bertocco, Sandra; Vitturi, Nicola; Polentarutti, Valentina; Deriu, GIOVANNI PAOLO; Grego, Franco; Bertipaglia, Barbara; Rattazzi, Marcello; Vianello, Daniela; Deeb, Ss; Pauletto, Paolo
Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol
1998 Zambon, Alberto; DEEB S., S; HOKANSON J., E; Brunzell, J. D.
COMPOSITIONAL DIFFERENCES OF LOW DENSITY LIPOPROTEIN (LDL) PARTICLES IN NORMAL SUBJECTS WITH LDL PHENOTYPE A AND LDL PHENOTYPE B
1996 Capell, W; Zambon, Alberto; Austin, M. A.; Brunzell, J. D.; Hokanson, J. E.
Consenso sobre tratamiento farmacológico de la dislipidemia aterogénica con terapia combinada estatina-fenofibrato
2016 Aguiar, Carlos; Alegría, Eduardo; Bonnadonna, Ricardo C.; Catapano, Alberico L.; Consentido, Francesco; Elisaf, Moses; Farnier, Michel; Fierrières, Jean; Filardi, Pasquale Perronre; Hancu, Nicolae; Kayikcioglu, Meral; Mello e. Silva, Alberto; Millán, Jesús; Reiner, Zeljko; Tokgozoglu, Lale; Valensi, Paul; Viigimaa, Margas; Vrablik, Michal; Zambon, Alberto; Zamorano, José Luis; Ferrari, Roberto; Blasco, Mariano; Brea, Ángel; Díaz, Ángel; Santos, Pedro Gonzáles; Mijares, Antonio Hernández; Mantilla, Teresa; Pedro Botet, Juan; Pintó, Xavier